NeoMass AAAC 3.0
Enhanced newborn screening with expanded marker panel for precise detection of genetic disorders.
Overview
The NeoMass AAAC 3.0 is an advanced upgrade of the NeoMass AAAC Plus kit. It retains the same extraction process but expands the marker panel to include Nucleoside and Lysophospholipid, enabling sensitive and specific detection of adenosine deaminase (ADA) deficiency and X-linked adrenoleukodystrophy (XALD).
Analytes Measured :
- 15 Amino Acids
- 13 Acyl Carnitines
- Argininosuccinic Acid (ASA)
- Succinylacetone (SUAC)
- Lysophospholipid
- Nucleoside
Features
- Screening of up to 50 disorders in a single injection
- Single-run protocol for streamlined workflow
- Three levels of dried blood spot controls covering the clinically valid range
- Simple four-step processing: Punch → Extract → Transfer → Analyze
- No additional incubation or assay buffer required for SUAC quantification
- High-throughput analysis measuring each sample in 1.5 minutes
- Shortest extraction time for rapid results
Technical Specifications
- Simple protein precipitation method
- High recovery for all analytes including SUAC, Lysophospholipid, and Nucleoside (Adenosine)
- No derivatization required
- Internal standards validated for long-term stability